Target Name: CD79A
NCBI ID: G973
Review Report on CD79A Target / Biomarker Content of Review Report on CD79A Target / Biomarker
CD79A
Other Name(s): Ig-alpha | Surface-IgM-associated protein | ig-alpha | CD79a molecule, immunoglobulin-associated alpha | membrane-bound immunoglobulin-associated protein | MB1 | B-cell antigen receptor complex associated protein alpha-chain | B-cell antigen receptor complex-associated protein alpha chain | Surface IgM-associated protein | B-cell antigen receptor complex-associated protein alpha chain (isoform 1) | MB-1 membrane glycoprotein | surface IgM-associated protein | MB-1 | CD79a antigen (immunoglobulin-associated alpha) | IGA | CD79a | CD79A variant 1 | Membrane-bound immunoglobulin associated protein | IGAlpha | CD79a molecule, transcript variant 1 | CD79A_HUMAN | Membrane-bound immunoglobulin-associated protein | CD79a molecule

CD79A as a Potential Drug Target and Biomarker: Unlocking the Potential of Ig-alpha

Abstract:
Ig-alpha, a type of immunoglobulin fragment, has been identified as a potential drug target and biomarker for various diseases. Its unique structure and functions make it an attractive target for the development of new treatments. This article will discuss the biology and potential applications of Ig-alpha, highlighting its functions as a drug target and biomarker, and its potential in the development of new treatments.

Introduction:
Ig-alpha is a type of immunoglobulin fragment that is produced by the B cells in response to the presence of foreign substances in the body. It is composed of a single chain of five immunoglobulin subunits and has unique functions in the immune system. One of the key functions of Ig-alpha is its ability to interact with other immune cells, including T cells andNK cells, allowing it to contribute to the immune response.

In addition to its role in the immune system, Ig-alpha has also been shown to have various physiological functions. For example, it has been shown to play a role in regulating inflammation, promoting wound healing, and maintaining skin health.

CD79A: A Potential Drug Target

CD79A is a protein that is expressed in various tissues and cells, including the brain, liver, and gastrointestinal tract. It is characterized by its ability to interact with the protein PDGF-BB, which is a key regulator of cell growth and differentiation.

The interaction between CD79A and PDGF-BB has led to the hypothesis that CD79A may be a drug target for the treatment of various diseases. One of the key reasons for this is the fact that CD79A has been shown to play a role in the regulation of cellular processes that are important in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its role in the regulation of cellular processes, CD79A has also been shown to interact with various proteins that are involved in the development of diseases. For example, it has been shown to interact with the protein ID4, which is involved in the development of neurodegenerative diseases, and with the protein ITGA2, which is involved in the development of autoimmune diseases.

CD79A as a Biomarker

In addition to its potential as a drug target, CD79A has also been shown to be a valuable biomarker for the diagnosis and prognosis of various diseases. For example, it has been shown to be elevated in the blood of individuals with cancer, and to be associated with the poor prognosis of neurodegenerative diseases.

In addition to its use as a biomarker, CD79A has also been shown to be involved in the development of diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been shown to interact with the protein tau, which is involved in the development of these diseases.

Conclusion:
In conclusion, CD79A is a protein that has unique functions in the immune system and has been shown to play a role in the regulation of various cellular processes that are important in the development and progression of many diseases. Its interaction with PDGF-BB and various proteins involved in the development of diseases makes it a potential drug target and biomarker for the treatment of various diseases. Further research is needed to fully understand the role of CD79A in the immune system and its potential as a drug target and biomarker.

Protein Name: CD79a Molecule

Functions: Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B-cells

The "CD79A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD79A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18 | CDH19 | CDH2 | CDH20 | CDH22 | CDH23 | CDH24 | CDH26 | CDH3 | CDH4 | CDH5 | CDH6 | CDH7 | CDH8 | CDH9 | CDHR1 | CDHR18P | CDHR2 | CDHR3 | CDHR4 | CDHR5 | CDIN1